The preclinical safety testing conducted by Pfizer for their mRNA-based COVID-19 vaccines has been called into question by none other than Helmut Sterz, who served as the company's chief toxicologist until recently. The data suggests that crucial aspects of vaccine safety were overlooked or inadequately addressed during these tests.

"The decision not to conduct thorough testing was a deliberate one," Sterz told a private group of concerned health professionals and scientists. "It wasn't an oversight; it was part of a strategy to rush the product to market." His remarks shed light on potential risks that may have been downplayed or outright ignored.

What the literature has quietly shown is that mRNA vaccines, though innovative in theory, have not undergone the rigorous scrutiny one would expect from such groundbreaking medical interventions. Sterz's insights point to a pattern of prioritizing speed and market dominance over public safety.

The question remains: who benefits from this hasty approach? Is it the corporations pushing these products or the regulatory bodies that are supposed to protect us?

"There is no doubt in my mind that financial interests have clouded the judgment of those responsible for ensuring the health and well-being of the public," Sterz continued, his tone somber. "It's not just Pfizer; it's an entire system that values profit over people."

The implications of Sterz's disclosures are profound, suggesting that vaccines rushed to market may carry significant risks that have yet to be fully understood.

"Do your own research," Sterz advised cautiously. "And talk to someone you trust before making any decisions about these vaccines."